Detalhe da pesquisa
1.
A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function.
Blood;
125(11): 1822-5, 2015 Mar 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25634741
2.
Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.
Circulation;
128(3): 254-66, 2013 Jul 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23817575
3.
Thrombin activation of the factor XI dimer is a multistaged process for each subunit.
J Thromb Haemost;
22(5): 1336-1346, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38242207
4.
The design and characterization of receptor-selective APRIL variants.
J Biol Chem;
287(44): 37434-46, 2012 Oct 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22961987
5.
Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma.
Proc Natl Acad Sci U S A;
107(20): 9083-7, 2010 May 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20439754
6.
Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
Blood;
116(8): 1336-43, 2010 Aug 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20462962
7.
A FRET-based assay for the quantitation of the thrombin-factor XI interaction.
Thromb Res;
214: 23-28, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35452868
8.
Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen.
J Thromb Haemost;
20(11): 2538-2549, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35815349
9.
Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex.
J Innate Immun;
: 1-21, 2022 May 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35551129
10.
Structure-function of anticoagulant TIX-5, the inhibitor of factor Xa-mediated FV activation.
J Thromb Haemost;
19(7): 1697-1708, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33829620
11.
The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
FASEB J;
23(5): 1584-95, 2009 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19141538
12.
Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa.
J Thromb Haemost;
17(12): 2047-2055, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31519061
13.
Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI.
Thromb Haemost;
118(2): 340-350, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29378358
14.
Evolutionary conservation of the lipopolysaccharide binding site of ß2-glycoprotein I.
Thromb Haemost;
106(6): 1069-75, 2011 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21947351
15.
Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B.
Thromb Haemost;
106(4): 609-16, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21800008
16.
Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor.
J Biol Chem;
279(8): 6620-8, 2004 Feb 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14660622
17.
Beta2-glycoprotein I is incorrectly named apolipoprotein H.
J Thromb Haemost;
7(1): 235-6, 2009 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19017258
18.
Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosis.
Br J Haematol;
118(2): 604-9, 2002 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12139754